Patent directory · USPTO A61K / A61P
Patents matching “Corcept Therapeutics Incorporated”
120 pharma patents match "Corcept Therapeutics Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 120 pharmaceutical patents matching "Corcept Therapeutics Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12370175
Glucocorticoid receptor modulators to treat pancreatic cancer
granted -
US 12370188
Formulations of dazucorilant, a glucocorticoid receptor modulator
granted -
US 12336985
Methods for shrinking pituitary tumors
granted -
US 12290551
Methods for imaging and treatment of somatostatin-receptor positive tumors
granted -
US 12285425
Glucocorticoid receptor modulators to treat cervical cancer
granted -
US 12263169
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
granted -
US 12226412
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 12226417
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
granted -
US 12171760
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
granted -
US 12152028
Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
granted -
US 12144812
Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators
granted -
US 12139486
Octahydro fused azadecalin glucocorticoid receptor modulators
granted -
US 12109272
Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers
granted -
US 12102642
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
granted -
US 12097210
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 12098141
Bicyclic indazole glucocorticoid receptor antagonists
granted -
US 12097192
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
granted -
US 12098144
Piperazine indazole glucocorticoid receptor antagonists
granted -
US 12018001
Pyrimidine cyclohexenyl glucocorticoid receptor modulators
granted -
US 12005055
Methods for shrinking pituitary tumors
granted -
US 11969435
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 11944617
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
granted -
US 11925626
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted -
US 11903945
Methods of treating antipsychotic-induced weight gain with miricorilant
granted